Galectin-3 as TREM2 upstream factor contributes to lung ischemia-reperfusion injury by regulating macrophage polarization

[1]  A. MacKinnon,et al.  Selective Myeloid Depletion of Galectin-3 Offers Protection Against Acute and Chronic Lung Injury , 2021, Frontiers in Pharmacology.

[2]  S. Wu,et al.  [Role and regulatory mechanism of triggering receptor expressed on myeloid cells 2 in mice lung ischemia/reperfusion injury]. , 2021, Zhonghua wei zhong bing ji jiu yi xue.

[3]  Chunjie Jiang,et al.  Quercetin Attenuates Atherosclerotic Inflammation by Inhibiting Gal-3-NLRP3 Signaling Pathway. , 2021, Molecular nutrition & food research.

[4]  M. Schwaiger,et al.  Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (89Zr)-DFO- Galectin3-F(ab')2 mAb , 2021, Theranostics.

[5]  Z. Li,et al.  Inhibition of p38 MAPK Mitigates Lung Ischemia Reperfusion Injury by Reducing Blood–Air Barrier Hyperpermeability , 2020, Frontiers in Pharmacology.

[6]  Lin Fei,et al.  Preconditioning with rHMGB1 ameliorates lung ischemia–reperfusion injury by inhibiting alveolar macrophage pyroptosis via the Keap1/Nrf2/HO-1 signaling pathway , 2020, Journal of Translational Medicine.

[7]  Xu-xin Chen,et al.  Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome , 2020, Inflammation Research.

[8]  John H. Zhang,et al.  TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice , 2020, Journal of Neuroinflammation.

[9]  Jianliang Fu,et al.  Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/ TLR4/ NF-κB pathways in BV2 cells. , 2019, Molecular immunology.

[10]  A. Cohen-Solal,et al.  Acute Kidney Injury Induces Remote Cardiac Damage and Dysfunction Through the Galectin-3 Pathway , 2019, JACC. Basic to translational science.

[11]  R. D. Rudic,et al.  Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension. , 2019, Antioxidants & redox signaling.

[12]  Jing Gong,et al.  Ac2-26 ameliorates lung ischemia-reperfusion injury via the eNOS pathway. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  Hui-Mei Chen,et al.  Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington’s disease , 2019, Nature Communications.

[14]  Ryosuke Nakano,et al.  DNAX Activating Protein of 12 kDa/Triggering Receptor Expressed on Myeloid Cells 2 Expression by Mouse and Human Liver Dendritic Cells: Functional Implications and Regulation of Liver Ischemia–Reperfusion Injury , 2019, Hepatology.

[15]  P. Mulder,et al.  Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition , 2019, Scientific Reports.

[16]  S. Chiou,et al.  Induced Pluripotent Stem Cells Regulate Triggering Receptor Expressed on Myeloid Cell‐1 Expression and the p38 Mitogen‐Activated Protein Kinase Pathway in Endotoxin‐Induced Acute Lung Injury , 2019, Stem cells.

[17]  Sara Linse,et al.  Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease , 2019, Acta Neuropathologica.

[18]  F. Jaisser,et al.  CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation: Mechanistic Insights and Clinical Implications , 2019, Hypertension.

[19]  J. Kupiec-Weglinski,et al.  Myeloid HO-1 modulates macrophage polarization and protects against ischemia-reperfusion injury. , 2018, JCI insight.

[20]  J. T. Afshari,et al.  Macrophage plasticity, polarization, and function in health and disease , 2018, Journal of cellular physiology.

[21]  Xiaofang Huang,et al.  The Role of Macrophages in the Pathogenesis of ALI/ARDS , 2018, Mediators of inflammation.

[22]  L. Lavra,et al.  Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z , 2018, International journal of molecular sciences.

[23]  Hsi-Yuan Huang,et al.  Krüppel-Like Factor 4 Regulation of Cholesterol-25-Hydroxylase and Liver X Receptor Mitigates Atherosclerosis Susceptibility , 2017, Circulation.

[24]  L. Xiong,et al.  Triggering Receptor Expressed on Myeloid Cells 2, a Novel Regulator of Immunocyte Phenotypes, Confers Neuroprotection by Relieving Neuroinflammation , 2017, Anesthesiology.

[25]  Long-Jun Wu,et al.  TREM2 protects against cerebral ischemia/reperfusion injury , 2017, Molecular Brain.

[26]  D. Kober,et al.  TREM2-Ligand Interactions in Health and Disease. , 2017, Journal of molecular biology.

[27]  Saheli Samanta,et al.  Macrophage polarization in response to epigenetic modifiers during infection and inflammation. , 2017, Drug discovery today.

[28]  V. Laubach,et al.  Mechanisms of lung ischemia-reperfusion injury , 2016, Current opinion in organ transplantation.

[29]  L. Punzi,et al.  Galectin-3 in autoimmunity and autoimmune diseases , 2015, Experimental biology and medicine.

[30]  Irene Garcia,et al.  Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ Macrophages , 2015, Front. Immunol..

[31]  T. Rőszer,et al.  Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms , 2015, Mediators of inflammation.

[32]  D. Laskin,et al.  Regulation of ozone-induced lung inflammation and injury by the β-galactoside-binding lectin galectin-3. , 2015, Toxicology and applied pharmacology.

[33]  K. Blomgren,et al.  Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation. , 2015, Cell reports.

[34]  G. Besra,et al.  Gal‐3 regulates the capacity of dendritic cells to promote NKT‐cell‐induced liver injury , 2015, European journal of immunology.

[35]  S. Gordon,et al.  The M1 and M2 paradigm of macrophage activation: time for reassessment , 2014, F1000prime reports.

[36]  S. Gill,et al.  Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury. , 2012, American journal of respiratory cell and molecular biology.

[37]  N. Arsenijević,et al.  Galectin‐3 deficiency prevents concanavalin A–induced hepatitis in mice , 2012, Hepatology.

[38]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[39]  Kevin C. Haudek,et al.  Dynamics of galectin-3 in the nucleus and cytoplasm. , 2010, Biochimica et biophysica acta.

[40]  J. Meldolesi,et al.  The surface‐exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor , 2009, Journal of neurochemistry.

[41]  N. Câmara,et al.  A Role for galectin‐3 in renal tissue damage triggered by ischemia and reperfusion injury , 2008, Transplant international : official journal of the European Society for Organ Transplantation.

[42]  N. Van Rooijen,et al.  Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. , 2003, The Journal of thoracic and cardiovascular surgery.

[43]  Michael J. Davis,et al.  Shuttling of galectin-3 between the nucleus and cytoplasm. , 2002, Glycobiology.

[44]  Myoung-Gwi Ryou,et al.  An In Vitro Oxygen-Glucose Deprivation Model for Studying Ischemia-Reperfusion Injury of Neuronal Cells. , 2018, Methods in molecular biology.

[45]  L. Punzi,et al.  Role of galectin-3 in autoimmune and non-autoimmune nephropathies. , 2017, Autoimmunity reviews.